These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10808042)

  • 1. Increased growth hormone response to sumatriptan challenge in adult autistic disorders.
    Novotny S; Hollander E; Allen A; Mosovich S; Aronowitz B; Cartwright C; DeCaria C; Dolgoff-Kaspar R
    Psychiatry Res; 2000 May; 94(2):173-7. PubMed ID: 10808042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder.
    Hollander E; Novotny S; Allen A; Aronowitz B; Cartwright C; DeCaria C
    Neuropsychopharmacology; 2000 Feb; 22(2):163-7. PubMed ID: 10649829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumatriptan challenge in bipolar patients with and without migraine: a neuroendocrine study of 5-HT1D receptor function.
    Mahmood T; Silverstone T; Connor R; Herbison P
    Int Clin Psychopharmacol; 2002 Jan; 17(1):33-6. PubMed ID: 11800504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subcutaneous sumatriptan on plasma growth hormone concentrations in migraine patients.
    Pinessi L; Rainero I; Savi L; Valfrè W; Limone P; Calvelli P; Del Rizzo P; Gianotti L; Taliano M; Ghigo E; Arvat E
    Cephalalgia; 2000 May; 20(4):223-7. PubMed ID: 10999671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone response to sumatriptan (5-HT1D agonist) challenge in seasonal affective disorder: effects of light therapy.
    Yatham LN; Lam RW; Zis AP
    Biol Psychiatry; 1997 Jul; 42(1):24-9. PubMed ID: 9193738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519.
    Longmore J; Boulanger CM; Desta B; Hill RG; Schofield WN; Taylor AA
    Br J Clin Pharmacol; 1996 Oct; 42(4):431-41. PubMed ID: 8904614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
    Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
    Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased sensitivity of 5-HT1D receptors in chronic tension-type headache.
    Rainero I; Valfrè W; Savi L; Ferrero M; Del Rizzo P; Limone P; Isaia GC; Gianotti L; Pollo A; Verde R; Benedetti F; Pinessi L
    Headache; 2002 Sep; 42(8):709-14. PubMed ID: 12390633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?
    Whale R; Bhagwagar Z; Cowen PJ
    Psychopharmacology (Berl); 1999 Jul; 145(2):223-6. PubMed ID: 10463324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal 5-HT1D receptor function in major depression: a neuropharmacological challenge study using sumatriptan.
    Cleare AJ; Murray RM; Sherwood RA; O'Keane V
    Psychol Med; 1998 Mar; 28(2):295-300. PubMed ID: 9572087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.
    Koran LM; Pallanti S; Quercioli L
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):169-72. PubMed ID: 11313163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
    Bouchelet I; Case B; Olivier A; Hamel E
    Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of defective serotonergic and GABAergic controls of growth hormone secretion in long-term abstinent alcoholics.
    Vescovi PP; Coiro V
    Alcohol Alcohol; 1997; 32(1):85-90. PubMed ID: 9131896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective 5-HT 1-receptor-mediated neurotransmission in the control of growth hormone secretion in Parkinson's disease.
    Volpi R; Caffarra P; Scaglioni A; Boni S; Saginario A; Chiodera P; Coiro V
    Neuropsychobiology; 1997; 35(2):79-83. PubMed ID: 9097298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal 5-HT1D receptor function in cluster headache: a neuroendocrine study with sumatriptan.
    Pinessi L; Rainero I; Valfrè W; Lo Giudice R; Ferrero M; Rivoiro C; Arvat E; Gianotti L; Del Rizzo P; Limone P
    Cephalalgia; 2003 Jun; 23(5):354-60. PubMed ID: 12780765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan.
    Miller KJ; King A; Demchyshyn L; Niznik H; Teitler M
    Eur J Pharmacol; 1992 Sep; 227(1):99-102. PubMed ID: 1330643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder.
    Pian KL; Westenberg HG; van Megen HJ; den Boer JA
    Psychopharmacology (Berl); 1998 Dec; 140(3):365-70. PubMed ID: 9877016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operational characteristics of the 5-HT1-like receptors mediating external carotid vasoconstriction in vagosympathectomized dogs. Close resemblance to the 5-HT1D receptor subtype.
    Villalón CM; Sánchez-López A; Centurión D
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):550-6. PubMed ID: 8938651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan decreases food intake and increases plasma growth hormone in healthy women.
    Boeles S; Williams C; Campling GM; Goodall EM; Cowen PJ
    Psychopharmacology (Berl); 1997 Jan; 129(2):179-82. PubMed ID: 9040124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.